Nov 4, 4:30 PM ET
HP's Board appointed Emma Walmsley, former CEO of GSK, as Chief Executive Officer effective January 4, 2027, succeeding interim CEO Bruce Broussard, who will become Board Chair on the same date and succeed Chip Bergh. The filing discloses her offer letter terms, including a $1,450,000 base salary, a $30,000,000 one-time inducement equity award and a $2,500,000 sign-on bonus, and the Board increases its authorized directorships from 12 to 13 to seat her. The filing contains no financial results, so the change is a leadership transition whose effect on performance is not stated.
- Emma Walmsley, 57, served as GSK CEO from April 2017 until December 2025 and joins HP as CEO on January 4, 2027.
- Bruce Broussard, interim CEO since February 2026, becomes Board Chair on January 4, 2027, succeeding Chip Bergh.
- Offer letter sets a $1,450,000 annual base salary and a 200% target bonus, with a $30,000,000 one-time inducement equity award.
- Walmsley receives a $2,500,000 sign-on bonus, subject to prorated repayment if she leaves voluntarily or is terminated for misconduct within 12 months.
Read the filing on SEC.gov ↗
Aug 26, 4:17 PM ET
HP reported fiscal third-quarter 2026 net revenue of $15.7 billion, up 12.5% from a year earlier, and non-GAAP diluted EPS of $0.83, up 11%. GAAP diluted EPS fell 11% to $0.71 from $0.80, and both figures include an $0.11 benefit from tariff refunds. HP raised its fiscal 2026 non-GAAP EPS and free cash flow outlook, which matters to shareholders because it signals stronger expected full-year profit and cash generation.
- Q3 net revenue was $15.7 billion, up 12.5% from $13.9 billion in the prior-year quarter.
- Non-GAAP diluted EPS was $0.83, up from $0.75; GAAP diluted EPS was $0.71, down from $0.80.
- Fiscal 2026 non-GAAP diluted EPS outlook raised to $3.19 to $3.29; GAAP outlook raised to $2.52 to $2.62.
- Fiscal 2026 free cash flow outlook raised to $3.0 to $3.2 billion; Q3 returned $0.6 billion to shareholders.
Read the filing on SEC.gov ↗
May 27, 4:17 PM ET
HP reported fiscal 2026 second-quarter results on May 27, 2026, with net revenue of $14.4 billion, up 9.0%, and non-GAAP diluted EPS of $0.86, up 21.1%. GAAP diluted EPS of $0.49 was below the company's prior outlook of $0.52 to $0.58, and restructuring and other charges reached $365 million, and HP updated its fiscal 2026 EPS and free cash flow estimates.
- Net revenue of $14.4 billion, up 9.0% year over year; GAAP diluted EPS of $0.49, up from $0.42 but below the prior outlook of $0.52 to $0.58
- Non-GAAP diluted EPS of $0.86, up from $0.71 and above the prior outlook of $0.70 to $0.76
- Restructuring and other charges of $365 million in the quarter, compared with $122 million a year earlier
- Fiscal 2026 estimates: GAAP diluted EPS $2.15 to $2.45, non-GAAP diluted EPS $2.90 to $3.10, free cash flow $2.8 to $3.0 billion
Read the filing on SEC.gov ↗
Apr 21, 5:07 PM ET
At its April 16, 2026 annual meeting, HP Inc. stockholders approved the Fifth Amended and Restated 2004 Stock Incentive Plan, which makes 73,600,000 additional common shares available for share-based awards. Stockholders also re-elected twelve directors, ratified Ernst & Young as auditor for fiscal 2026, and approved executive pay in an advisory vote. A stockholder proposal for an independent board chairman was rejected.
- Plan approval: 495,892,067 votes for and 159,248,223 against, with 2,380,622 abstentions
- Plan adds 73,600,000 shares of common stock for share-based compensation awards
- Twelve directors elected, including Chip Bergh, Richard L. Clemmer and Gianluca Pettiti
- Independent board chairman proposal failed: 105,071,429 for and 547,764,193 against
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.